Literature DB >> 8311843

From receptor internalization to nuclear translocation. New targets for long-term pharmacology.

P M Laduron1.   

Abstract

Receptors involved in intercellular communication at the cell surface share the capacity to desensitize through molecular and cellular mechanisms. Cellular desensitization is a rapid and dynamic process whereby membrane receptors internalize in response to an excess of agonists. The internalized receptors may recycle rapidly or undergo down-regulation when following a degradative pathway. However, receptor internalization does not necessarily mean degradation; it also represents the initial step of a retrograde signalling system whereby an "interiorized" message, the ligand-receptor complex, can be transported in contrast to second messengers, along axons or in the cytoplasm leading to long-term effects in the nucleus. Such "third messengers" have to undergo nuclear translocation to serve as transcriptional regulators in the control of gene expression. The "third messengers" are thus cytoplasmic proteins, including the receptor itself, which may be associated with internalized vesicles and released by mechanisms which have not yet been elucidated. They represent already good targets for the development of new drugs, and multi-targeting and synergistic approaches are likely to increase their usefulness.

Mesh:

Substances:

Year:  1994        PMID: 8311843     DOI: 10.1016/0006-2952(94)90431-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors:  S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 3.  Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

4.  Loligomers: design of de novo peptide-based intracellular vehicles.

Authors:  K Sheldon; D Liu; J Ferguson; J Gariépy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.